Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134002) titled 'A Prospective, Multicenter, Randomized, Parallel-Controlled Superiority Study Evaluating the Efficacy and Safety of a Transcatheter Intramyocardial Septal Radiofrequency Ablation System in Patients With Obstructive Hypertrophic Cardiomyopathy' on Oct. 10.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Capital Medical University Affiliated Beijing Anzhen Hospital
Condition:
Hypertrophic Cardiomyopathy, Obstructive
Intervention:
Intervention group:Participants in this group will receive a transcatheter intramyocardial septal radiofrequency ablation under intracardiac echocardiograph...